[HTML] cell.com

[HTML][HTML] mRNA-1273 and BNT162b2 mRNA vaccines have reduced neutralizing activity against the SARS-CoV-2 omicron variant

VV Edara, KE Manning, M Ellis, L Lai, KM Moore… - Cell Reports …, 2022 - cell.com
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) omicron variant
emerged in November 2021 and consists of several mutations within the spike. We use …
被引用次数：200 相关文章

mRNA-1273 and BNT162b2 mRNA vaccines have reduced neutralizing activity against the SARS-CoV-2 Omicron variant

VV Edara, KE Manning, M Ellis, L Lai, KM Moore… - bioRxiv, 2021 - biorxiv.org
Abstract The BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna) vaccines generate
potent neutralizing antibodies against severe acute respiratory syndrome coronavirus 2 …
[HTML] sciencedirect.com

[HTML][HTML] mRNA-1273 and BNT162b2 mRNA vaccines have reduced neutralizing activity against the SARS-CoV-2 omicron variant

VV Edara, KE Manning, M Ellis, L Lai, KM Moore… - Cell Reports …, 2022 - Elsevier
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) omicron variant
emerged in November 2021 and consists of several mutations within the spike. We use …

mRNA-1273 and BNT162b2 mRNA vaccines have reduced neutralizing activity against the SARS-CoV-2 Omicron variant

VV Edara, KE Manning, M Ellis, L Lai, KM Moore… - 2021 - pesquisa.bvsalud.org
mRNA-1273 and BNT162b2 mRNA vaccines have reduced neutralizing activity against the
SARS-CoV-2 Omicron variant | PREPRINT-BIORXIV loading 1 2 3 +A A -A 3.mRNA-1273 and …

mRNA-1273 and BNT162b2 mRNA vaccines have reduced neutralizing activity against the SARS-CoV-2 omicron variant.

VV Edara, KE Manning, M Ellis, L Lai… - Cell reports …, 2022 - europepmc.org
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) omicron variant
emerged in November 2021 and consists of several mutations within the spike. We use …

[引用][C] mRNA-1273 and BNT162b2 mRNA vaccines have reduced neutralizing activity against the SARS-CoV-2 omicron variant

VV Edara, KE Manning, M Ellis, L Lai, KM Moore… - Cell Reports …, 2022 - cir.nii.ac.jp
mRNA-1273 and BNT162b2 mRNA vaccines have reduced neutralizing activity against the
SARS-CoV-2 omicron variant | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ …

mRNA-1273 and BNT162b2 mRNA vaccines have reduced neutralizing activity against the SARS-CoV-2 omicron variant

VV Edara, KE Manning, M Ellis, L Lai… - Cell reports …, 2022 - pubmed.ncbi.nlm.nih.gov
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) omicron variant
emerged in November 2021 and consists of several mutations within the spike. We use …
[HTML] nih.gov

[HTML][HTML] mRNA-1273 and BNT162b2 mRNA vaccines have reduced neutralizing activity against the SARS-CoV-2 omicron variant

VV Edara, KE Manning, M Ellis, L Lai… - Cell Reports …, 2022 - ncbi.nlm.nih.gov
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) omicron variant
emerged in November 2021 and consists of several mutations within the spike. We use …

mRNA-1273 and BNT162b2 mRNA vaccines have reduced neutralizing activity against the SARS-CoV-2 Omicron variant

VV Edara, KE Manning, M Ellis, L Lai, KM Moore… - 2021 - pesquisa.bvsalud.org
mRNA-1273 and BNT162b2 mRNA vaccines have reduced neutralizing activity against the
SARS-CoV-2 Omicron variant | PREPRINT-BIORXIV loading 1 2 3 +A A -A 3.mRNA-1273 and …

mRNA-1273 and BNT162b2 mRNA vaccines have reduced neutralizing activity against the SARS-CoV-2 Omicron variant

VV Edara, KE Manning, M Ellis, L Lai, KM Moore… - bioRxiv - ncbi.nlm.nih.gov
Abstract The BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna) vaccines generate
potent neutralizing antibodies against severe acute respiratory syndrome coronavirus 2 …